News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InSpire MD to Announce Six-Month Results From The MGuard™ Embolic Protection Stent (EPS) MASTER Trial at EuroPCR


5/17/2013 6:57:34 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BOSTON and TEL AVIV, Israel, May 16, 2013 /PRNewswire/ –

InspireMD, Inc. (“InspireMD” or the “Company”) (NYSE MKT: NSPR), the leader in embolic protection stents, today announced a robust schedule of educational events and data presentations at EuroPCR, culminating in the first presentation of 6-month results from the MASTER (MGuardfor Acute STElevation Reperfusion) trial of the Company’s MGuard™ Embolic Protection Stent (EPS).

Help employers find you! Check out all the jobs and post your resume.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES